Welcome to our dedicated page for Hyster-Yale SEC filings (Ticker: HY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating how much Hyster-Yale spent on hydrogen fuel-cell R&D or when executives last bought shares often means wading through hundreds of pages. Stock Titan turns every Hyster-Yale filing into an easy read, delivering AI-powered summaries that surface the lift-truck backlog, regional demand shifts and cash-flow changes in seconds.
Need the Hyster-Yale quarterly earnings report 10-Q filing or want to monitor Hyster-Yale insider trading Form 4 transactions? We stream documents from EDGAR the moment they post and translate them into clear takeaways. Our platform links each disclosure type to the metric you care about:
- Form 4 alerts highlight Hyster-Yale executive stock transactions Form 4 in real time.
- 10-Ks are annotated so the Hyster-Yale annual report 10-K simplified shows segment margins and dealer-financing risk at a glance.
- 8-Ks flag material events—see Hyster-Yale 8-K material events explained minutes after filing.
- DEF 14A reports decode Hyster-Yale proxy statement executive compensation without legal jargon.
Our AI answers the questions investors actually ask—“How cyclical is lift-truck demand?” or “What’s hidden in the warranty reserve footnote?”—while embedding long-tail queries like Hyster-Yale SEC filings explained simply, understanding Hyster-Yale SEC documents with AI, and Hyster-Yale earnings report filing analysis. From Hyster-Yale Form 4 insider transactions real-time to nuanced Bolzoni attachment revenue trends, every disclosure is parsed so you can act faster and invest smarter.
David B. Williams, a director of Hyster-Yale, Inc. (HY), acquired 963 Class A common shares on 10/01/2025. The shares were issued as "Required Shares" under the companys Non-Employee Directors Equity Compensation Plan and were reported at a $0 price, reflecting a grant rather than a purchase. The filing lists extensive indirect holdings attributed to the reporting person through spouse, trusts, and partnership interests, including large blocks of Class A shares underlying Class B holdings reported in Table II. The reporting person disclaims beneficial ownership of several indirectly held positions. The Form 4 was signed by an attorney-in-fact on 10/02/2025.
Claiborne R. Rankin, a director of Hyster-Yale, Inc. (HY), reported an acquisition of 963 shares of Class A common stock on 10/01/2025 as "Required Shares" under the companys Non-Employee Directors Equity Compensation Plan. After the reported transaction, the filing shows 243,245 shares of Class A common stock beneficially owned by the reporting person, largely held indirectly through trusts, limited partnerships and interests attributed to the reporting persons spouse. The Form 4 discloses multiple indirect holdings and trustee roles rather than open-market purchases or sales, and the reporting person disclaims beneficial ownership for certain trust-held shares.
Reporting person: Poor Vincent, listed as a director of HYSTER-YALE, INC. (HY). On 10/01/2025 Mr. Vincent was awarded 963 shares of Class A Common Stock as "Required Shares" under the company's Non-Employee Directors' Equity Compensation Plan at a reported price of $0. After the award he beneficially owned 20,451 shares, held directly. The Form 4 was signed by an attorney-in-fact, Suzanne S. Taylor, on 10/02/2025.
This filing documents a routine equity award to a director recorded as a non-derivative acquisition; it shows the change in direct beneficial ownership and identifies the award as compensation-related under the director equity plan.
The reporting person, John P. Jumper, a director of Hyster-Yale, received 963 shares of Class A common stock as award "Required Shares" under the companys Non-Employee Directors' Equity Compensation Plan. Following the transaction the reporting person beneficially owns 26,837 shares of Class A common stock. The Form 4 indicates this was a non-derivative acquisition recorded with transaction code A and a $0 price, consistent with stock awards issued as compensation to a director.
Carolyn Corvi, a director of HYSTER-YALE, INC. (HY), reported an acquisition of 963 shares of Class A common stock on 10/01/2025. The reported transaction code is A (acquisition) at a reported price of $0.00, leaving her with 26,185 shares beneficially owned following the transaction. The Form 4 was signed by an attorney-in-fact on 10/02/2025. The filing is a single-person Form 4 and lists the reporting person as a director.
Gary Collar L, a director of HYSTER-YALE, INC. (HY), received equity awards on 10/01/2025 under the company's Non-Employee Directors' Equity Compensation Plan. The filing shows two grant entries: 963 shares issued as "Required Shares" and 648 shares issued as "Voluntary Shares," both with a $0 price, indicating they were awarded rather than purchased. After the transactions the reporting person is shown as directly owning 6,729 shares of Class A common stock. The Form 4 was signed by an attorney-in-fact on 10/02/2025.
John C. Butler Jr., a director of Hyster-Yale, Inc. (HY), reported an acquisition of Class A common stock on 10/01/2025. The Form 4 shows an award of 963 Class A shares to the reporting person at a $0 price described as "Required Shares" under the company's Non-Employee Directors' Equity Compensation Plan. The filing lists a variety of indirect holdings held in trusts, partnerships, and an IRA, including 56,985 shares held in a trust for the reporting person and additional indirect interests across family trusts and partnerships. The filing was signed by an attorney-in-fact on 10/02/2025.
James Bemowski, a director of HYSTER-YALE, INC. (HY), was awarded 963 shares of Class A Common Stock on 10/01/2025 as required equity compensation for non-employee directors. Following this award, Bemowski beneficially owns 18,683 shares of Class A Common Stock. The transaction is reported as an acquisition at a $0 price because these were award shares issued under the company Non-Employee Directors' Equity Compensation Plan.
The Form 4 filing was executed on 10/02/2025 by Suzanne S. Taylor as attorney-in-fact. The report is a single-person filing and identifies Bemowski as a director. No derivative transactions, cash payments, or changes to previously reported holdings are disclosed in this form.
HYSTER-YALE director Colleen Batcheler reported acquiring 963 Class A Common Stock shares on 10/01/2025 at $0 per share as "Required Shares" under the company's Non-Employee Directors' Equity Compensation Plan. After the award, the reporting person beneficially owns 6,816 shares indirectly, held in trust. The Form 4 was filed by a single reporting person and signed by an attorney-in-fact on 10/02/2025. The disclosure indicates a routine equity grant to a director rather than a market purchase or sale.
John P. Jumper, a director of Hyster-Yale, Inc. (HY), reported a transaction dated 09/09/2025 exchanging 326 Class B shares for 326 Class A shares under transaction code J(1). After the exchange he beneficially owns 25,874 shares of Class A common stock and no derivative securities. The Form 4 was signed by an attorney-in-fact on 09/11/2025 and states the exchange converted the reporting person’s Class B shares into Class A shares; no cash consideration was reported.
FAQ
What is the current stock price of Hyster-Yale (HY)?
What is the market cap of Hyster-Yale (HY)?
